Connected Drug Delivery Devices Market Analysis 2026

Factors Affecting Injectable devices
Inhalation Devices Market Growth

• Increase in the shift of patients towards advanced drug delivery systems

The increase in the shift of patients towards advanced products is due to reduced variability in systemic drug concentrations and increased ability to distribute pharmaceuticals more precisely and selectively to a specific site. These features have increased the demand for a connected drug delivery market. In addition to this, its ability to provide less frequent dosing, increased absorption that is more consistent with the site and mechanism of action, and reductions in toxic metabolites are the factor involved in rising the demand for connected drug delivery devices. Furthermore, the digitalization of medical devices has increased the awareness of advanced products among patients. The digitalization system provides various advantages such as needle-free injection, controlled dosage, and higher flexibility of self-administration, leading to an increase in the adoption of devices.

The Restraining Factor of Injectable devices
Inhalation Devices:

• Concerns about patient/ user data security:

However, concerns regarding patient data security are predicted to restrain the connected drug delivery devices market. The loss of crucial data such as insurance IDs and medical records that may contain bank information, medical information, and location may have a negative impact on patient data privacy and affect the manufacturer's reputation for connected medication delivery systems. 
Due to the threat of cyber security, hospitals, patients, and outside service providers are all in severe danger. Such serious and significant dangers associated with connected drug delivery device solutions could lower market revenue. This is expected to slow the market's expansion for connected drug delivery devices.

Impact of the COVID-19 Pandemic on the Connected Drug Delivery Devices Market:

The outbreak of COVID-19 has negatively affected the world and increased the demand for healthcare facilities. This accelerated the trend toward improving the healthcare system for better support and a growing rate of technological innovation. In 2020, despite difficult conditions and a lockdown in most of the globe's nations, the connected medicine delivery devices sector showed remarkable expansion. The lockdown restrictions caused an unexpected rise in demand for connected drug delivery systems for use in-home care, which in turn increased demand for standalone drug delivery systems. As a result, during the past few years, connected drug delivery device utilization has increased. 
However, in June 2020, the digital health startup, Propeller Health, partnered with Novartis. Through this collaboration, the Enerzair Breezhaler has been co-packed by Propeller's digital health platform for the efficient treatment of asthmatic patients. Furthermore, the Enerzair Breezhaler inhaler includes sensors installed by Propeller Health that transmit data to the Propeller mobile application on the patient's smartphone. These initiatives and technological developments might result in the creation of lucrative business prospects for the expansion of the connected drug delivery systems market globally. Companies all over the world are winning the public's trust and working to create more opportunities for the global connected drug delivery devices market in the projected period.

Our study will explain complete manufacturing process along with major raw materials required to manufacture end-product. This report helps to make effective decisions determining product position and will assist you to understand opportunities and threats around the globe.

The Global Connected Drug Delivery Devices Market is witnessing significant growth in the near future.

In 2023, the Injectable devices segment accounted for noticeable share of global Connected Drug Delivery Devices Market and is projected to experience significant growth in the near future.

The Asthma segment is expected to expand at the significant CAGR retaining position throughout the forecast period.

Some of the key companies Propeller Health , BioCorp and others are focusing on its strategy building model to strengthen its product portfolio and expand its business in the global market.

Frequently Asked Questions